Pharmaceutical Statistics Special Issue Just Published: In Honour of Andy Grieve: Professional, Practical and Methodological Issues in Pharmaceutical Statistics

Pharmaceutical Statistics has just published a special issue in honour of Andy Grieve to celebrate his 70th birthday, guest edited by Stephen Senn and Mike K. Smith, with a foreword by Sir Adrian Smith.

The authors of the assembled papers have either collaborated with Andy as a colleague or co-author or have been influenced by his work. Their varied and interesting contributions, which, as is fitting in view of the scope of Andy’s work, cover professional, practical, and methodological aspects of biostatistics as applied to the pharmaceutical industry.

The articles in the issue are:

Smith, MK. Reflecting on Andy Grieve’s influence and innovation: A personal perspective. Pharmaceutical Statistics. 2022; 21( 4): 702705. doi:10.1002/pst.2220
 
Jones, M, Hodgson, G. Do statisticians count? A prior and posterior viewpoint. Pharmaceutical Statistics. 2022; 21( 4): 706711. doi:10.1002/pst.2229
 
Walley, R, Brayshaw, N. From innovative thinking to pharmaceutical industry implementation: Some success stories. Pharmaceutical Statistics. 2022; 21( 4): 712719. doi:10.1002/pst.2222
 
Kirby, S, Chuang-Stein, C. The Acute Stroke Therapy by Inhibition of Neutrophils study – Key features and impact. Pharmaceutical Statistics. 2022; 21( 4): 720728. doi:10.1002/pst.2218
 
Müller, P, Duan, Y, Garcia Tec, M. Simulation-based sequential design. Pharmaceutical Statistics. 2022; 21( 4): 729739. doi:10.1002/pst.2216
 
Weir, CJ, Taylor, RS. Informed decision-making: Statistical methodology for surrogacy evaluation and its role in licensing and reimbursement assessments. Pharmaceutical Statistics. 2022; 21( 4): 740756. doi:10.1002/pst.2219. OPEN ACCESS
 
Maurer, W, Bretz, F, Posch, M. Rationale for the update algorithm of the graphical approach to sequentially rejective multiple test procedures. Pharmaceutical Statistics. 2022; 21( 4): 757763. doi:10.1002/pst.2227
 
Bird, SM. Study-design in pandemics: From surveillance and performance-evaluation to licensing and pharmacovigilance. Pharmaceutical Statistics. 2022; 21( 4): 764777. doi:10.1002/pst.2217  OPEN ACCESS
 
Garrett, AD. The cross-over of statistical thinking and practices: A pandemic catalyst. Pharmaceutical Statistics. 2022; 21( 4): 778789. doi:10.1002/pst.2221 FREE ACCESS
 
Senn, S. The design and analysis of vaccine trials for COVID-19 for the purpose of estimating efficacy. Pharmaceutical Statistics. 2022; 21( 4): 790807. doi:10.1002/pst.2226 OPEN ACCESS
 
Senn, S. Viewpoint: Do not resurrect the two-stage procedure. Pharmaceutical Statistics. 2022; 21( 4): 808814. doi:10.1002/pst.2224
 
More Details